89 related articles for article (PubMed ID: 25967130)
1. Use of 18F-fluoride positron emission tomography as a predictor of the hip osteoarthritis progression.
Kobayashi N; Inaba Y; Yukizawa Y; Ike H; Kubota S; Inoue T; Saito T
Mod Rheumatol; 2015; 25(6):925-30. PubMed ID: 25967130
[TBL] [Abstract][Full Text] [Related]
2. Comparison of 18F-fluoride positron emission tomography and magnetic resonance imaging in evaluating early-stage osteoarthritis of the hip.
Kobayashi N; Inaba Y; Tateishi U; Ike H; Kubota S; Inoue T; Saito T
Nucl Med Commun; 2015 Jan; 36(1):84-9. PubMed ID: 25230054
[TBL] [Abstract][Full Text] [Related]
3. Validity and reliability of three definitions of hip osteoarthritis: cross sectional and longitudinal approach.
Reijman M; Hazes JM; Pols HA; Bernsen RM; Koes BW; Bierma-Zeinstra SM
Ann Rheum Dis; 2004 Nov; 63(11):1427-33. PubMed ID: 15479891
[TBL] [Abstract][Full Text] [Related]
4. New application of 18F-fluoride PET for the detection of bone remodeling in early-stage osteoarthritis of the hip.
Kobayashi N; Inaba Y; Tateishi U; Yukizawa Y; Ike H; Inoue T; Saito T
Clin Nucl Med; 2013 Oct; 38(10):e379-83. PubMed ID: 23603593
[TBL] [Abstract][Full Text] [Related]
5. Prediction of femoral head collapse in osteonecrosis using 18F-fluoride positron emission tomography.
Kubota S; Inaba Y; Kobayashi N; Tateishi U; Ike H; Inoue T; Saito T
Nucl Med Commun; 2015 Jun; 36(6):596-603. PubMed ID: 25714808
[TBL] [Abstract][Full Text] [Related]
6. The prognostic and diagnostic value of 18F-FDG PET/CT for assessment of symptomatic osteoarthritis.
Nguyen BJ; Burt A; Baldassarre RL; Smitaman E; Morshedi M; Kao S; Chang EY; Obrzut S
Nucl Med Commun; 2018 Jul; 39(7):699-706. PubMed ID: 29893752
[TBL] [Abstract][Full Text] [Related]
7. Quantification of progressive joint space narrowing in osteoarthritis of the hip: longitudinal analysis of the contralateral hip after total hip arthroplasty.
Goker B; Doughan AM; Schnitzer TJ; Block JA
Arthritis Rheum; 2000 May; 43(5):988-94. PubMed ID: 10817550
[TBL] [Abstract][Full Text] [Related]
8. Correlation between mechanical stress by finite element analysis and 18F-fluoride PET uptake in hip osteoarthritis patients.
Hirata Y; Inaba Y; Kobayashi N; Ike H; Yukizawa Y; Fujimaki H; Tezuka T; Tateishi U; Inoue T; Saito T
J Orthop Res; 2015 Jan; 33(1):78-83. PubMed ID: 25251583
[TBL] [Abstract][Full Text] [Related]
9. Natural history of radiographic hip osteoarthritis: A retrospective cohort study with 11-28 years of followup.
Franklin J; Ingvarsson T; Englund M; Ingimarsson O; Robertsson O; Lohmander LS
Arthritis Care Res (Hoboken); 2011 May; 63(5):689-95. PubMed ID: 21557524
[TBL] [Abstract][Full Text] [Related]
10. Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women.
Lane NE; Nevitt MC; Hochberg MC; Hung YY; Palermo L
Arthritis Rheum; 2004 May; 50(5):1477-86. PubMed ID: 15146417
[TBL] [Abstract][Full Text] [Related]
11. Early determination of prognosis by interim 3'-deoxy-3'-18F-fluorothymidine PET in patients with non-Hodgkin lymphoma.
Lee H; Kim SK; Kim YI; Kim TS; Kang SH; Park WS; Yun T; Eom HS
J Nucl Med; 2014 Feb; 55(2):216-22. PubMed ID: 24365650
[TBL] [Abstract][Full Text] [Related]
12. Validity, reliability, and applicability of seven definitions of hip osteoarthritis used in epidemiological studies: a systematic appraisal.
Reijman M; Hazes JM; Koes BW; Verhagen AP; Bierma-Zeinstra SM
Ann Rheum Dis; 2004 Mar; 63(3):226-32. PubMed ID: 14962953
[TBL] [Abstract][Full Text] [Related]
13. [
Tibrewala R; Bahroos E; Mehrabian H; Foreman SC; Link TM; Pedoia V; Majumdar S
J Orthop Res; 2019 Dec; 37(12):2671-2680. PubMed ID: 31424110
[TBL] [Abstract][Full Text] [Related]
14. 18F-FDG PET and combined 18F-FDG-contrast CT parameters as predictors of tumor control for hepatocellular carcinoma after stereotactic ablative radiotherapy.
Huang WY; Kao CH; Huang WS; Chen CM; Chang LP; Lee MS; Chao HL; Chiu CH; Lo CH; Jen YM
J Nucl Med; 2013 Oct; 54(10):1710-6. PubMed ID: 23970365
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal assessment of MRI in hip osteoarthritis using SHOMRI and correlation with clinical progression.
Schwaiger BJ; Gersing AS; Lee S; Nardo L; Samaan MA; Souza RB; Link TM; Majumdar S
Semin Arthritis Rheum; 2016 Jun; 45(6):648-55. PubMed ID: 27162009
[TBL] [Abstract][Full Text] [Related]
16. Role of radiography in predicting progression of osteoarthritis of the hip: prospective cohort study.
Reijman M; Hazes JM; Pols HA; Bernsen RM; Koes BW; Bierma-Zeinstra SM
BMJ; 2005 May; 330(7501):1183. PubMed ID: 15894555
[TBL] [Abstract][Full Text] [Related]
17. Role of SUV(max) obtained by 18F-FDG PET/CT in patients with a solitary pancreatic lesion: predicting malignant potential and proliferation.
Hu SL; Yang ZY; Zhou ZR; Yu XJ; Ping B; Zhang YJ
Nucl Med Commun; 2013 Jun; 34(6):533-9. PubMed ID: 23503000
[TBL] [Abstract][Full Text] [Related]
18. Dual energy x-ray absorptiometry analysis contributes to the prediction of hip osteoarthritis progression.
Betancourt MC; Linden JC; Rivadeneira F; Rozendaal RM; Zeinstra SM; Weinans H; Waarsing JH
Arthritis Res Ther; 2009; 11(6):R162. PubMed ID: 19883507
[TBL] [Abstract][Full Text] [Related]
19. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
20. Prediction of occult lymph node metastasis by metabolic parameters in patients with clinically N0 esophageal squamous cell carcinoma.
Moon SH; Kim HS; Hyun SH; Choi YS; Zo JI; Shim YM; Lee KH; Kim BT; Choi JY
J Nucl Med; 2014 May; 55(5):743-8. PubMed ID: 24700884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
